These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 33971040)

  • 1. Anthracycline treatment, cardiovascular risk factors and the cumulative incidence of cardiovascular disease in a cohort of newly diagnosed lymphoma patients from the modern treatment era.
    Boddicker NJ; Larson MC; Castellino A; Herrmann J; Inwards DJ; Thanarajasingam G; Maurer MJ; Allmer C; Witzig TE; Nowakowski GS; Habermann TM; Villarraga HR; Slager SL; Cerhan JR; Thompson CA
    Am J Hematol; 2021 Aug; 96(8):979-988. PubMed ID: 33971040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Anthracycline With Heart Failure in Patients Treated for Breast Cancer or Lymphoma, 1985-2010.
    Larsen CM; Garcia Arango M; Dasari H; Arciniegas Calle M; Adjei E; Rico Mesa J; Scott CG; Thompson CA; Cerhan JR; Haddad TC; Goetz MP; Herrmann J; Villarraga HR
    JAMA Netw Open; 2023 Feb; 6(2):e2254669. PubMed ID: 36735254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk.
    van Nimwegen FA; Schaapveld M; Janus CP; Krol AD; Petersen EJ; Raemaekers JM; Kok WE; Aleman BM; van Leeuwen FE
    JAMA Intern Med; 2015 Jun; 175(6):1007-17. PubMed ID: 25915855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in US breast cancer survivors.
    Vo JB; Ramin C; Veiga LHS; Brandt C; Curtis RE; Bodelon C; Barac A; Roger VL; Feigelson HS; Buist DSM; Bowles EJA; Gierach GL; Berrington de González A
    J Natl Cancer Inst; 2024 Aug; 116(8):1384-1394. PubMed ID: 38718210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of cardiovascular disease after radiotherapy in survivors of breast cancer: A case-cohort study.
    Hamood R; Hamood H; Merhasin I; Keinan-Boker L
    J Cardiol; 2019 Apr; 73(4):280-291. PubMed ID: 30587455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials.
    Maraldo MV; Giusti F; Vogelius IR; Lundemann M; van der Kaaij MA; Ramadan S; Meulemans B; Henry-Amar M; Aleman BM; Raemaekers J; Meijnders P; Moser EC; Kluin-Nelemans HC; Feugier P; Casasnovas O; Fortpied C; Specht L;
    Lancet Haematol; 2015 Nov; 2(11):e492-502. PubMed ID: 26686259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular disease incidence in adolescent and young adult cancer survivors: a retrospective cohort study.
    Keegan THM; Kushi LH; Li Q; Brunson A; Chawla X; Chew HK; Malogolowkin M; Wun T
    J Cancer Surviv; 2018 Jun; 12(3):388-397. PubMed ID: 29427203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease after childhood acute lymphoblastic leukaemia: a cohort study.
    Hau EM; Caccia JN; Kasteler R; Spycher B; Suter T; Ammann RA; von der Weid NX; Kuehni CE
    Swiss Med Wkly; 2019 Feb; 149():w20012. PubMed ID: 30852834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late cardiotoxicity after treatment for Hodgkin lymphoma.
    Aleman BM; van den Belt-Dusebout AW; De Bruin ML; van 't Veer MB; Baaijens MH; de Boer JP; Hart AA; Klokman WJ; Kuenen MA; Ouwens GM; Bartelink H; van Leeuwen FE
    Blood; 2007 Mar; 109(5):1878-86. PubMed ID: 17119114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study.
    Chung IY; Lee JW; Moon HG; Shin KH; Han W; Son BH; Ahn SH; Noh DY
    Breast; 2020 Oct; 53():125-129. PubMed ID: 32771950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
    Baech J; Hansen SM; Lund PE; Soegaard P; Brown PN; Haaber J; Jørgensen J; Starklint J; Josefsson P; Poulsen CB; Juul MB; Torp-Pedersen C; El-Galaly TC
    Br J Haematol; 2018 Dec; 183(5):717-726. PubMed ID: 30406945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery calcium and cardiovascular outcomes in patients with lymphoma undergoing autologous hematopoietic cell transplantation.
    Wu S; Rhee JW; Iukuridze A; Bosworth A; Chen S; Atencio L; Manubolu V; Bhandari R; Jamal F; Mei M; Herrera A; Rodriguez F; Forman S; Nakamura R; Wong FL; Budoff M; Armenian SH
    Cancer; 2024 Jun; 130(12):2205-2214. PubMed ID: 38358333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daytime sleepiness predicts mortality and cardiovascular disease in older adults. The Cardiovascular Health Study Research Group.
    Newman AB; Spiekerman CF; Enright P; Lefkowitz D; Manolio T; Reynolds CF; Robbins J
    J Am Geriatr Soc; 2000 Feb; 48(2):115-23. PubMed ID: 10682939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midlife Ankylosing Spondylitis Increases the Risk of Cardiovascular Diseases in Males 5 Years Later: A National Population-Based Study.
    Hung YM; Chang WP; Wei JC; Chou P; Wang PY
    Medicine (Baltimore); 2016 May; 95(18):e3596. PubMed ID: 27149491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preexisting Cardiovascular Risk and Subsequent Heart Failure Among Non-Hodgkin Lymphoma Survivors.
    Salz T; Zabor EC; de Nully Brown P; Dalton SO; Raghunathan NJ; Matasar MJ; Steingart R; Vickers AJ; Svenssen Munksgaard P; Oeffinger KC; Johansen C
    J Clin Oncol; 2017 Dec; 35(34):3837-3843. PubMed ID: 28922087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer.
    Pinder MC; Duan Z; Goodwin JS; Hortobagyi GN; Giordano SH
    J Clin Oncol; 2007 Sep; 25(25):3808-15. PubMed ID: 17664460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of developing cardiovascular disease is increased for patients with prostate cancer who are pharmaceutically treated for depression.
    Wollersheim BM; Boekhout AH; van der Poel HG; van de Poll-Franse LV; Schoormans D
    BJU Int; 2020 Mar; 125(3):433-441. PubMed ID: 31773851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident Cardiovascular Diseases Among Survivors of High-Risk Stage II-III Colorectal Cancer: A Cluster-Wide Cohort Study.
    Lee SF; Yip PL; Vellayappan BA; Chee CE; Wong LC; Wan EY; Chan EW; Lee CF; Lee FA; Luque-Fernandez MA
    J Natl Compr Canc Netw; 2022 Oct; 20(10):1125-1133.e10. PubMed ID: 36240841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.